I lead the gastrointestinal clinical research programme at Hammersmith Hospital, Imperial College London. I am on the UK National Cancer Research Institute steering committee of both the advanced colorectal cancer and upper gastrointestinal groups, as well as the inaugural chair of the West London Cancer Network.
I am involved in the Trial management of many CRC studies including one of the largest metastatic colorectal cancer studies in the world (COIN study), and the chief investigator (CI) in its sub-study (COIN-B), as well as a co-investigator on the largest prospective study in chemotherapy in the elderly (FOCUS-2) which reports in 2007. I am on the European working party on CRC liver metastases guidance.
In upper gastrointestinal cancer I am Co-PI and PI in the UK NRCN trials portfolio in advanced Biliary cancer and Cancer of unknown primary, with the latter two designed to be the largest studies of their kind in the world. I am a fellow of the Royal College of Physicians and the Oncology advisor to the UK Drugs and Therapeutics Bulletin (DTB) amongst many other national consultative roles.
Treatment information
Some of the principal treatments carried out by Dr Harpreet Wasan at Spire include:
Other treatments
- Bladder cancer treatment
- Hormone therapy treatment
- Kidney cancer treatment
- Liver cancer treatment
- Oesophageal cancer treatment
- Pancreatic cancer
- Prostate cancer treatment
- Skin cancer - facial skin cancer removal
- Stomach cancer treatment
- Testicular cancer
Get in touch
Important information about Covid-19 tests
COVID-19 testing or antibody tests are not available as a standalone service at Spire Thames Valley Hospital.
Additional information
Current NHS posts
Hammersmith Hospital
Contact information
| Telephone | 01753 665 404 |
| Private secretary | Maxine Reid |
| Private secretary telephone | 020 8383 3170 |
| Private secretary email | wasan@cancer.org.uk |